ONCOTELIC THERAPEUTICS, INC.
Profile
Company Names
ONCOTELIC THERAPEUTICS, INC.
MATEON THERAPEUTICS INC
OXIGENE INC
Addresses
29397 AGOURA ROAD, SUITE 107, AGOURA HILLS, CA 91301
29397 AGOURA ROAD, SUITE 107, AGOURA HILLS, CA 91301
701 GATEWAY BLVD., SUITE 210, SOUTH SAN FRANCISCO, CA 94080
701 GATEWAY BOULEVARD, SUITE 210, SOUTH SAN FRANCISCO, CA 94080
Phone Numbers
650-635-7000
0
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$13,300,000.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2025-12-04
$275,000.00
$12,500,000.00
$12,225,000.00
Equity, Debt
4
2020-07-23
$2,000,000.00
$5,000,000.00
$3,000,000.00
Equity, Debt
3
2019-04-22
$600,000.00
$1,200,000.00
$600,000.00
Equity, Debt
2
2018-04-12
$2,925,000.00
$12,000,000.00
$9,075,000.00
Equity
1
2010-03-12
$7,500,000.00
$7,500,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROY
H.
FICKLING
DIRECTOR
MARK
KESSEL
DIRECTOR
BOBBY
W.
SANDAGE, JR.
DIRECTOR
AMIT
SHAH
EXECUTIVE OFFICER
ZYME SOLUTIONS INC
| PICTUREMAX, L.P.
| GUAVUS INC
| LIGHTWIRE INC
| DYYNO INC
| ADAMA MATERIALS, INC.
| INSIGHTRA MEDICAL, INC.
| HOMEUNION HOLDINGS, INC.
| NIRON MAGNETICS, INC.
| MARINA BIOTECH, INC.
| DNA LODGING EAST HARTFORD LLC
| MARIUS PHARMACEUTICALS, LLC
| MATEON THERAPEUTICS INC
| VISBY MEDICAL, INC.
| CROSSBAR, INC.
VUONG
TRIEU
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
NO REVENUES
Equity, Debt
2025-12-04
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2020-07-23
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2019-04-22
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-04-22
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2018-04-12
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2010-03-12
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
